Compounds > yohimbine
Page last updated: 2024-08-20

yohimbine and reboxetine

yohimbine has been researched along with reboxetine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrot, M; Doridot, S; Freund-Mercier, MJ; Hein, L; Petit-Demoulière, N; Tessier, LH; Yalcin, I1
Conrad, KL; Davis, AR; Javitch, JA; Lindsley, CW; Matthies, HJ; Saleh, SA; Sen, N; Sheffler, DJ; Shields, AD; Silberman, Y; Winder, DG1
Duarte, ID; Guzzo, LS; Resende, LC; Romero, TR1

Other Studies

3 other study(ies) available for yohimbine and reboxetine

ArticleYear
Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.
    Neurobiology of disease, 2009, Volume: 33, Issue:3

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amines; Animals; Anticonvulsants; Antidepressive Agents; Cyclohexanecarboxylic Acids; Cyclohexanols; Desipramine; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Mice, Transgenic; Morpholines; Pain; Pain Threshold; Propanolamines; Reboxetine; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Sciatic Nerve; Venlafaxine Hydrochloride; Yohimbine

2009
Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:10

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Animal; Cocaine; Drug-Seeking Behavior; Extinction, Psychological; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Orexin Receptors; Orexins; Patch-Clamp Techniques; Reboxetine; Receptors, Adrenergic, alpha-2; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide; Reward; Septal Nuclei; Synaptic Transmission; Yohimbine

2012
CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Anesthesia and analgesia, 2013, Volume: 116, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amides; Analgesics; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Dinoprostone; Endocannabinoids; Ethanolamines; Male; Morpholines; Norepinephrine; Pain Measurement; Palmitic Acids; Peripheral Nerves; Polyunsaturated Alkamides; Prazosin; Propranolol; Rats; Rats, Wistar; Reboxetine; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sympathetic Nervous System; Yohimbine

2013